On the contrary, it is reported that LRG1 is an inhibitor for adverse cardiac remodeling, and its deficiency aggravates myocardial fibrosis with cardiac dysfunction after myocardial infarction (35, 36). Here, LRG1 is linked to myocardial infarction.